Sangamo Therapeutics and Bioverativ Therapeutics Begin New Clinical Trial for Transfusion-Dependent Beta-Thalassemia » ThalesStudy_FinalBrochure_Page_1


This entry was posted on Friday, April 6th, 2018 at 8:43 pm and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

Secured By miniOrange